Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;32(3):231-8.
doi: 10.1080/13803390902926184. Epub 2009 May 29.

Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status

Kevin Duff  1 , Leigh J Beglinger, Danielle Theriault, Jessica Allison, Jane S Paulsen
Affiliations

Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status

Kevin Duff et al. J Clin Exp Neuropsychol. 2010 Mar.

Abstract

Huntington's disease (HD) is associated with a variety of cognitive deficits, as well as motor and psychiatric disturbances. As clinical trials for HD evolve, briefer screening instruments will be needed to determine cognitive effects of interventions. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) may fill this gap. A total of 75 participants diagnosed with HD were evaluated with the RBANS, as well as several other scales typically used in HD. RBANS performances for these participants fell significantly below expectations for the Total Scale score, all five Indexes, and 11 of the 12 individual subtests. Cognitive scores on the RBANS were also significantly related to other markers of HD, including motor abnormalities, functional abilities, and other cognitive scores. Although additional research is needed, the current study supports the clinical applicability of the RBANS in patients with HD.

PubMed Disclaimer

References

    1. Arango-Lasprilla JC, Rogers H, Lengenfelder J, Deluca J, Moreno S, Lopera F. Cortical and subcortical diseases: do true neuropsychological differences exist? Arch Clin Neuropsychol. 2006;21:29–40. - PubMed
    1. Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Movement Disorders. 2000;15:552–560. - PubMed
    1. Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology. 1997;48:394–399. - PubMed
    1. Aylward EH, Rosenblatt A, Field K, Yallapragada V, Kieburtz K, McDermott M, et al. Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study. Brain Research Bulletin. 2003;62:137–141. - PubMed
    1. Beatty WW. RBANS analysis of verbal memory in multiple sclerosis. Arch Clin Neuropsychol. 2004;19:825–834. - PubMed